Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q2 EPS of ($0.27), $0.17 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $2.51 million versus the consensus estimate of $420 thousand.

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.